Chemotherapy News and Research

Latest Chemotherapy News and Research

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.

2 Jun 2004

Study may help oncologists tailor chemotherapy to patients based on their genetic make-up

Genetic variations in an individual’s ability to repair DNA damage may help predict survival in lung cancer patients treated with the common chemotherapy drugs cisplatin or carboplatin, a new study shows.

2 Jun 2004

Discovery of a key marker in breast cancer tumors

Cancer researchers at Georgetown University Medical Center have discovered a key marker in breast cancer tumors that may help determine which women with early stage breast cancer have a better chance of survival. The research appears in the June 1 issue of the Journal of Clinical Oncology.

31 May 2004

Invention could help numerous lymphedema patients around the world

After Ellen Van't Hof survived a bilateral mastectomy, six months of chemotherapy and two months of radiation she thought the worst was behind her.

30 May 2004

Combination of two types of radiation therapy is better for treating brain cancer

Adding stereotactic radiosurgery – which entails delivering radiation to specific points in the brain while sparing normal tissue – after whole brain radiation therapy helps certain patients with cancer that has spread to the brain live longer, says a new study by researchers at Thomas Jefferson University Hospital in Philadelphia.

25 May 2004

Results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer

Accuray Incorporated announced today the publication of the results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer.

25 May 2004

Baby born from 21 year old cryopreserved sperm

"We believe this is the longest period of sperm cryopreservation resulting in a live birth so far reported in the scientific literature," according to one of the authors, Dr Elizabeth Pease, Consultant in Reproductive Medicine at the Department of Reproductive Medicine at St Mary's Hospital, Manchester.

25 May 2004

X-ray beams could kick start genes into fighting cancer

X-ray beams could kick start genes into fighting cancer as an exciting new way of targeting therapy against the disease, according to new research in the Journal of Gene Medicine.

25 May 2004

Innovative new cancer drug enters the first phase of clinical trials

An innovative drug with a new mechanism of action that may be effective against a range of cancers will enter the first phase of clinical trials, it was announced today (Monday) at Cancer Research UK's Senior Researchers Meeting.

24 May 2004

Call to bring cancer genomics from the lab bench into large-scale clinical trials

Professor Patrick Johnston is one of a number of pioneering scientists exploring how intimate genetic knowledge from individual tumours could help doctors predict which treatments will benefit their patients best. Major trials of this approach – which has shown considerable success in the lab – are needed to test its full predictive potential.

24 May 2004

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation (HCT) and survive can expect full recovery to take 3-5 years, according to a study published in the May 19 issue of The Journal of the American Medical Association (JAMA).

19 May 2004

$First drug approved for hormone refractory prostate cancer that has shown a survival benefit$

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

19 May 2004

Drug combo effective for advanced breast cancer

A pair of studies at UCLA's Jonsson Cancer Center that takes laboratory science to the patients' bedside found that combining the molecularly targeted therapy Herceptin with a specific chemotherapy combination resulted in significant tumor response rates and longer relapse-free periods in women with an aggressive form of advanced breast cancer.

19 May 2004

New book highlights pros and cons of medical use of cannabis

A new book which brings together the relevant science regarding the beneficial effects of cannabis for identified medical conditions and explains many harmful side effects has been launched at Australia's Southern Cross University today.

19 May 2004

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

Inactivating a protective molecule in leukemic cells to make them more vulnerable to chemotherapy might also make healthy blood-forming cells more sensitive to the toxic effects of those same drugs.

19 May 2004

High levels of troponin I (TNI) protein in the blood helps identify possible heart damage after cancer treatment

TNI is a protein present exclusively in heart cells. The TNI blood concentration is a well-established marker of heart muscle injury that’s widely used to diagnose and treat heart attacks and other acute coronary syndromes.

18 May 2004

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

The Cleveland Clinic has been awarded a four-year, $1.4 million grant from the National Institutes of Health to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier. Researchers hope to use their findings to develop new methods to limit the damage caused by such events.

17 May 2004

Interventional radiologists now are able to treat using minimally invasive procedures

Interventional radiologists at Temple University Hospital now are able to treat many patients with minimally invasive procedures not available only a few years ago. “Conditions that used to require extensive surgery now take an hour or less, and patients leave with a bandaid and walk home,” says Gary Cohen, M.D., Section Chief of Interventional Radiology and Vice Chairman of Radiology. “How can you beat that?”

17 May 2004

Genetically engineered viruses may create new class of cancer therapies

A genetically engineered virus can selectively kill cancerous cells in the lung and colon while leaving healthy cells intact, according to new research published today in Cancer Research by William Wold and colleagues at Saint Louis University School of Medicine.

15 May 2004

Vitamin discovery offers clues for cancer chemotherapy

NH-Dartmouth Medical School cancer researchers, in a fusion of biochemistry and genetics, have discovered a new vitamin in a molecular pathway central to such vital processes as gene regulation, metabolism and aging. And, they found that milk contains this nutrient.

15 May 2004

Chemotherapy News and Research

Latest Chemotherapy News and Research

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Study may help oncologists tailor chemotherapy to patients based on their genetic make-up

Discovery of a key marker in breast cancer tumors

Invention could help numerous lymphedema patients around the world

Combination of two types of radiation therapy is better for treating brain cancer

Results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer

Baby born from 21 year old cryopreserved sperm

X-ray beams could kick start genes into fighting cancer

Innovative new cancer drug enters the first phase of clinical trials

Call to bring cancer genomics from the lab bench into large-scale clinical trials

Patients with leukemia or lymphoma who undergo hematopoietic-cell transplantation and survive can expect full recovery to take 3-5 years

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

Drug combo effective for advanced breast cancer

New book highlights pros and cons of medical use of cannabis

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

High levels of troponin I (TNI) protein in the blood helps identify possible heart damage after cancer treatment

$1.4 million to investigate how strokes and other events that cut off blood flow to the brain disrupt the blood-brain barrier

Interventional radiologists now are able to treat using minimally invasive procedures

Genetically engineered viruses may create new class of cancer therapies

Vitamin discovery offers clues for cancer chemotherapy

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in